Female radiologists, particularly those in leadership roles, remain relatively rare, particularly compared with other specialties. A quarterly Masters of Radiology Panel Discussion published in the January issue of American Journal of Roentgenology surveyed leaders about strategies to encourage more women to enter the radiology field and pursue leadership roles. The answers were varied and identified the lack of a quick fix.
Applying cardiac CT to the evaluation of patients who present to the emergency department (ED) with chest pain at low to intermediate risk of acute coronary syndrome saved money in both the initial diagnosis and over a one-year period, according to a decision analytic model published in the January issue of Academic Radiology.
Researchers at the University of Washington School of Medicine in Seattle have received a $7 million five-year renewal grant award from the National Institutes of Health (NIH)/National Cancer Institute (NCI) to continue research in molecular imaging of cancer and its response to therapy. This new award is funded through 2016.
The number of new cases of breast cancer diagnosed worldwide has risen dramatically from about 640,000 in 1980 to 1.6 million in 2010. During the same period, cervical cancer incidence and death rates have been decreasing, but the disease still killed 200,000 women in 2010, according to the first global estimates published Sept. 14 in The Lancet. The report shows that, in 2010, 51 percent of the 1.6 million new cases of breast cancer and 76 percent of the 425,000 new cases of cervical cancer occurred in developing countries.
Two decades of experts calling for value in Medicare reimbursement has gone largely unheeded. However, transitioning toward value-based reimbursement for imaging could optimize innovation and reward advances that deliver improved health and economic outcomes, according to an article published in the September issue of Academic Radiology.
18F-fluoroestradiol (FES) PET can assess the in vivo pharmacodynamics of estrogen receptor (ER)-targeted agents and may give insight into the activity of established therapeutic agents, according to a study in the August issue of Clinical Cancer Research.
18F-FDG uptake values measured by positron emission mammography (PEM) correlated with prognostic indicators that predict breast cancer survival and inform clinical management, including receptor status, tumor histology and tumor grade, according to a study published in the August issue of American Journal of Roentgenology.
Written by James Brice
A new day is dawning for breast cancer diagnosis, treatment and monitoring with the help of molecular imaging.
Written by Manjula Puthenedam, PhD
PET imaging is effective in staging, restaging, detecting recurrence and treatment monitoring across a wide range of cancers. This feature discusses updates on important PET imaging clinical trials in cancer care by the American College of Radiology Imaging Network and National Cancer Institute and focuses on improving cancer staging and predicting response to therapy. The National Oncology PET Registry (NOPR) recently published the results of the impact of dedicated brain PET on intended patient management and opened a registry for 18F-sodium fluoride PET to identify bone metastasis. The Cancer and Leukemia Group B (CALGB) sponsored by the NCI is another group conducting clinical trials in cancer, yet PET trials are still few.
|
|
|
|
RSS 
